Article Information
- Received May 22, 2000
- Revision received August 18, 2000
- Accepted September 1, 2000
- First published November 15, 2000.
- Version of record published November 15, 2000.
Author Information
- Yanyan Wang1,
- Rong Xu1,
- Toshikuni Sasaoka2,
- Susumu Tonegawa3,
- Mei-Ping Kung4, and
- Emma-Betty Sankoorikal1
- 1Departments of Pharmacology and
- 4Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084,
- 2Division of Cortical Function Disorders, National Institute of Neuroscience, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan, and
- 3Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Author contributions
Disclosures
- Received May 22, 2000.
- Revision received August 18, 2000.
- Accepted September 1, 2000.
This work was supported by grants to Y.W. from the National Alliance for Research on Schizophrenia and Depression, March of Dimes Birth Defects Foundation, Thomas and Jeannette McCabe Fund, University of Pennsylvania Research Foundation, and Whitehall Foundation and by grants to S.T. from the National Institutes of Health (NS 32925-07) and the Shionogi Institute for Medical Sciences. The process of making D2L knock-out mice was conducted in part at Dr. Tonegawa's laboratory. I (Y.W.) would like to thank many members in Dr. Tonegawa's laboratory for their suggestions and friendship and give special thanks to Drs. T. Iwasato, M. Wu, A. Ebralidze, and H. Prosser. We thank Dr. G. K. Aghajanian for useful suggestions, Dr. F. Jin for contribution to the immunohistochemical analysis, C. Hou and K.-L. Vukhac for technical assistance, Dr. D. Beitner-Johnson for editorial assistance, and J. Phillips for miscellaneous help.
Correspondence should be addressed to Dr. Yanyan Wang, Department of Pharmacology, University of Pennsylvania School of Medicine, M102 John Morgan, 3620 Hamilton Walk, Philadelphia, PA 19104-6084. E-mail:yywang{at}pharm.med.upenn.edu.
Online Impact